16+
Major trials tracked
A GLP-1/amylin combination against a GLP-1/GIP dual agonist
Cagrilintide vs tirzepatide: trial pipelines compared
A side-by-side view of the cagrilintide and tirzepatide clinical trial pipelines, built from live ClinicalTrials.gov data and refreshed daily. ClinicalTrials.gov lists 16+ phase 2–4 trials for cagrilintide and 16+ for tirzepatide. Add up to three more drugs to widen the comparison.
cagrilintide (16) vs tirzepatide (16)14 active2017–2031
cagrilintidetirzepatide
'17
'19
'21
'23
'25
'27
'29
'31
cagrilintide
Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.P2
REDEFINE 1P3
REDEFINE 2P3
REDEFINE 3P3
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose WeightP3
REDEFINE 6P3
REIMAGINE 2P3
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose WeightP3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorP3
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and PlaceboP2
REIMAGINE 5P3
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With ObesityP3
A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-termP3
RENEW 2P3
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightP3
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightP3
tirzepatide
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes MellitusP2
A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 DiabetesP3
SURPASS-3P3
SURPASS-5P3
SURMOUNT-OSAP3
SURPASS-CN-INSP3
TREASURE-CKDP2
A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesP3
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightP2
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose WeightP3
A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)P3
REIMAGINE 5P3
STOP KNEE-OAP4
STAY-LEANP4
GYMINDAP2
LOCITTP2
Upcoming readouts
11 ahead · 2 drugs
Select a trial to load its full ClinicalTrials.gov record.
Head to head
Registered phase 2–4 trial activity for each drug, computed from live ClinicalTrials.gov data.
cagrilintideGLP-1 & incretin therapies
14
Phase 3 trials
2
Actively recruiting
Mar 2027
Next phase 3 readout
tirzepatide (Mounjaro / Zepbound)GLP-1 & incretin therapies
16+
Major trials tracked
9
Phase 3 trials
2
Actively recruiting
None scheduled
Next phase 3 readout
Key trials across both drugs
Top 16 registered phase 2–4 trials across cagrilintide and tirzepatide, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track cagrilintide and tirzepatide with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Individual pipelines and other comparisons
FAQ
- How do the cagrilintide and tirzepatide clinical pipelines compare?
- ClinicalTrials.gov currently lists 16+ phase 2–4 trials for cagrilintide and 16+ for tirzepatide. The timeline above plots both side by side and refreshes daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily. ComplyRx does not add efficacy or superiority claims; the comparison shows registered trial activity only.
- Can I add more drugs to the comparison?
- Yes. The tool above compares up to five drugs on one timeline, with PNG and PDF export. Add any competitor in the search box.